130 related articles for article (PubMed ID: 27865470)
1. Preface.
Pruitt K
Prog Mol Biol Transl Sci; 2016; 144():xiii. PubMed ID: 27865470
[No Abstract] [Full Text] [Related]
2. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.
Lee JY; Kong G
Cell Mol Life Sci; 2016 Dec; 73(24):4643-4660. PubMed ID: 27460000
[TBL] [Abstract][Full Text] [Related]
3. Response.
Baker SG
J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766402
[No Abstract] [Full Text] [Related]
4. Conference Summary and Recent Advances: the 8th Conference on Metal Toxicity and Carcinogenesis.
Zhou X; Burchiel SW; Hudson LG; Liu KJ
Biol Trace Elem Res; 2015 Jul; 166(1):1-6. PubMed ID: 25975949
[TBL] [Abstract][Full Text] [Related]
5. Re: a cancer theory kerfuffle can lead to new lines of research.
Kaye FJ
J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766401
[No Abstract] [Full Text] [Related]
6. Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy.
McCubrey JA; Davis NM; Abrams SL; Montalto G; Cervello M; Basecke J; Libra M; Nicoletti F; Cocco L; Martelli AM; Steelman LS
Adv Biol Regul; 2014 Jan; 54():176-96. PubMed ID: 24169510
[No Abstract] [Full Text] [Related]
7. Is cancer a breakdown of multicellularity?
Pennisi E
Science; 2018 Jun; 360(6396):1391. PubMed ID: 29954963
[No Abstract] [Full Text] [Related]
8. One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?
Soto AM; Sonnenschein C
Bioessays; 2014 Jan; 36(1):118-20. PubMed ID: 24323923
[No Abstract] [Full Text] [Related]
9. Oncogenic epigenetic control.
Stein GS; Messier TL; Gordon JA; Boyd JR; Tye CE; Lian JB; Stein JL
Aging (Albany NY); 2016 Apr; 8(4):565-6. PubMed ID: 27038551
[No Abstract] [Full Text] [Related]
10. P53 tumor suppression network in cancer epigenetics.
Mishra A; Brat DJ; Verma M
Methods Mol Biol; 2015; 1238():597-605. PubMed ID: 25421682
[TBL] [Abstract][Full Text] [Related]
11. Special Issue " HPV and IGF axis in carcinogenesis".
Durzynska J
Mutat Res Rev Mutat Res; 2017; 772():1-2. PubMed ID: 28528683
[No Abstract] [Full Text] [Related]
12. The Methylated DNA Immunoprecipitation [MeDIP] to Investigate the Epigenetic Remodeling in Cell Fate Determination and Cancer Development.
Masciarelli S; Bellissimo T; Iosue I; Fazi F
Methods Mol Biol; 2016; 1379():69-76. PubMed ID: 26608290
[TBL] [Abstract][Full Text] [Related]
13. Biological techniques: An embryonic view of tumour development.
Schweiger PJ; Jensen KB
Nature; 2013 Sep; 501(7466):171-2. PubMed ID: 23945591
[No Abstract] [Full Text] [Related]
14. Mouse models: Novel in vivo RNAi screen in mice.
Lokody I
Nat Rev Cancer; 2013 Oct; 13(10):682. PubMed ID: 24030505
[No Abstract] [Full Text] [Related]
15. SMT and TOFT Integrable After All: A Reply to Bizzarri and Cucina.
Bedessem B; Ruphy S
Acta Biotheor; 2017 Mar; 65(1):81-85. PubMed ID: 27535677
[TBL] [Abstract][Full Text] [Related]
16. The insights of Let-7 miRNAs in oncogenesis and stem cell potency.
Sun X; Liu J; Xu C; Tang SC; Ren H
J Cell Mol Med; 2016 Sep; 20(9):1779-88. PubMed ID: 27097729
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer.
Ow SH; Chua PJ; Bay BH
Exp Biol Med (Maywood); 2017 Jan; 242(2):140-147. PubMed ID: 27633575
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs in cancer drug resistance development.
Majidinia M; Yousefi B
DNA Repair (Amst); 2016 Sep; 45():25-33. PubMed ID: 27427176
[TBL] [Abstract][Full Text] [Related]
19. Metabolic alteration in tumorigenesis.
Yang H; Xiong Y; Guan K
Sci China Life Sci; 2013 Dec; 56(12):1067-75. PubMed ID: 24114443
[TBL] [Abstract][Full Text] [Related]
20. Cancer epigenetics: risk assessment, diagnosis, treatment, and prognosis. Preface.
Verma M
Methods Mol Biol; 2015; 1238():v-vi. PubMed ID: 25568925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
